Project PLUS Lung Cancer Screening Promotion
Project PLUS is a pilot study that aims to develop and obtain preliminary feasibility and efficacy data on an enhanced risk communication approach to promote lung cancer screening (LCS) intentions among screening-eligible individuals from environmentally burdened communities. Project PLUS will combine qualitative interviews to explore subject awareness regarding lung cancer risk and air pollution, barriers to LCS, and perceptions regarding risk communication messaging, develop a health education video, and a between-subjects experiment to compare Data from this pilot will form the basis for enhanced community engagement efforts and subsequent communication research to examine the effectiveness of incorporating the involuntary air pollution risk information in risk communication interventions. The long term goal is to reduce lung cancer burden and disparities among environmentally burdened communities within and outside of Philadelphia.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Apr 22, 2025 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Interventions being studied
- Behavioral: Intervention video; Behavioral: Control video
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
Patient interview participants will be eligible if they: 1. Are ages 50 - 80 years; 2. Have a history of at least 20 cigarette pack-years, and who have quit within the past 15 years or are currently smoking; 3. Had a primary care visit at Penn Medicine within the last two years (2020-2021); 4. Have documented history of lung cancer screening or lung cancer 5. Are residing in one of 10 eligible zip codes; 6. Are English-speaking; 7. Are able to view the study videos; 8. Are able to participate in a video-conference interview using a HIPAA-compliant platform or able to participate in an interview over the phone. Pilot trial participants will be eligible if they: 1. Are ages 50 - 80 years; 2. Are documented history of at least 20 cigarette pack-years, and who have quit within the past 15 years or are currently smoking; 3. Have no documented history of lung cancer screening or lung cancer; 4. Did not participate in patient interviews; 5. Had a primary care visit at Penn Medicine within the last two years (2020-2022); 6. Are residing in one of 10 eligible zip codes; 7. Are English-speaking; 8. Are able to view the study videos and complete an online survey. Key
Patient interview participants are excluded if: a. They are not eligible for lung cancer screening. Pilot trial participants are excluded if they: 1. Do not meet inclusion criteria; 2. Participated in patient interviews.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of PennsylvaniaPhiladelphia, Pennsylvania
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 22, 2025. Always confirm current availability with the study team.